Skip to Main Content

Author Details

Sander Canisius
The Netherlands Cancer Institute
2011
34
21
Trey Ideker (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37961147Breast cancer risk SNPs converge on estrogen receptor binding sites commonly shared between breast tumors to locally alter estrogen signalling output.bioRxiv2023
34965952Differential Survival and Therapy Benefit of Patients with Breast Cancer Are Characterized by Distinct Epithelial and Immune Cell Microenvironments.Clin Cancer Res2022
34611289Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis.Sci Rep2021
34763270Contralateral parenchymal enhancement on MRI is associated with tumor proteasome pathway gene expression and overall survival of early ER+/HER2-breast cancer patients.Breast2021
34407845Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment.Breast Cancer Res2021
32193286Endonuclease FEN1 Coregulates ERα Activity and Provides a Novel Drug Interface in Tamoxifen-Resistant Breast Cancer.Cancer Res2020
31949161A network analysis to identify mediators of germline-driven differences in breast cancer prognosis.Nat Commun2020
33198768Breast cancer risk factors and their effects on survival: a Mendelian randomisation study.BMC Med2020
33022221Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk.Am J Hum Genet2020
32235890Integrative analysis of genomic amplification-dependent expression and loss-of-function screen identifies ASAP1 as a driver gene in triple-negative breast cancer progression.Oncogene2020
32452738Radiogenomic Analysis of Breast Cancer by Linking MRI Phenotypes with Tumor Gene Expression.Radiology2020
31150618Identifying Epistasis in Cancer Genomes: A Delicate Affair.Cell2019
31655316Are contralateral parenchymal enhancement on dynamic contrast-enhanced MRI and genomic ER-pathway activity in ER-positive/HER2-negative breast cancer related?Eur J Radiol2019
30379847Molecular characterization of breast and lung tumors by integration of multiple data types with functional sparse-factor analysis.PLoS Comput Biol2018
29861851Sponge-supported cultures of primary head and neck tumors for an optimized preclinical model.Oncotarget2018
26928228Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170.Nat Genet2016
26369632SRC3 Phosphorylation at Serine 543 Is a Positive Independent Prognostic Factor in ER-Positive Breast Cancer.Clin Cancer Res2016
27986087A novel independence test for somatic alterations in cancer shows that biology drives mutual exclusivity but chance explains most co-occurrence.Genome Biol2016
27792995Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21.Oncotarget2016
27640304Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation.Am J Hum Genet2016
27087578Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer.Int J Cancer2016
25529635Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1.Am J Hum Genet2015
26354892Fine-scale mapping of the 4q24 locus identifies two independent loci associated with breast cancer risk.Cancer Epidemiol Biomarkers Prev2015
26073781Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression.Am J Hum Genet2015
25890600Identification of novel genetic markers of breast cancer survival.J Natl Cancer Inst2015
25897948Common germline polymorphisms associated with breast cancer-specific survival.Breast Cancer Res2015
25751625Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.Nat Genet2015
25028367USP9X downregulation renders breast cancer cells resistant to tamoxifen.Cancer Res2014
22907427PKA phosphorylation redirects ERα to promoters of a unique gene set to induce tamoxifen resistance.Oncogene2013
23910573A gene signature for late distant metastasis in breast cancer identifies a potential mechanism of late recurrences.Mol Oncol2013
23535729Large-scale genotyping identifies 41 new loci associated with breast cancer risk.Nat Genet2013
22871386TRPM7 is required for breast tumor cell metastasis.Cancer Res2012
21667122Association of the germline TP53 R72P and MDM2 SNP309 variants with breast cancer survival in specific breast tumor subgroups.Breast Cancer Res Treat2011
22002538Oestrogen receptor-co-factor-chromatin specificity in the transcriptional regulation of breast cancer.EMBO J2011
  • 1 - 34 of 34

Recommended Authors

Matthew Ung
Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth
Career Start Year 2013
Number of shared co-authors 0
Kuan-Lin Huang
Icahn School of Medicine at Mount Sinai
Career Start Year 2013
Number of shared co-authors 0
Florentine S Hilbers
Netherlands Cancer Institute
Career Start Year 2012
Number of shared co-authors 19
Guanglong Jiang
Indiana University School of Medicine
Career Start Year 2011
Number of shared co-authors 0
Hans Kristian Moen Vollan
F Hoffmann-La Roche Ltd
Career Start Year 2010
Number of shared co-authors 6
Charlotte K Y Ng
University of Bern
Career Start Year 2009
Number of shared co-authors 6
Robert Lesurf
Ontario Institute for Cancer Research
Career Start Year 2008
Number of shared co-authors 3
Qiyuan Li
National Institute of Data Science in Health and Medicine, Xiamen University
Career Start Year 2008
Number of shared co-authors 59
David A Quigley
University of California-San Francisco
Career Start Year 2008
Number of shared co-authors 6
Eric C Polley
Mayo Clinic
Career Start Year 2007
Number of shared co-authors 43
Nicola Waddell
QIMR Berghofer Medical Research Institute
Career Start Year 2006
Number of shared co-authors 25
Christina Yau
University of California San Francisco
Career Start Year 2005
Number of shared co-authors 11
Chao Cheng
Baylor College of Medicine
Career Start Year 2005
Number of shared co-authors 1
Christina Curtis
Stanford University School of Medicine
Career Start Year 2004
Number of shared co-authors 12
Katherine A Hoadley
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Career Start Year 2004
Number of shared co-authors 8
Benjamin Haibe-Kains
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2004
Number of shared co-authors 4
Hisani N Horne
National Cancer Institute
Career Start Year 2004
Number of shared co-authors 31
Brooke L Fridley
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year 2003
Number of shared co-authors 65
Obi L Griffith
Washington University
Career Start Year 2003
Number of shared co-authors 3
Olivier Harismendy
University of California
Career Start Year 2003
Number of shared co-authors 3
Britta Weigelt
Memorial Sloan Kettering Cancer Center
Career Start Year 2002
Number of shared co-authors 14
Howard H Yang
Center for Cancer Research, National Cancer Institute
Career Start Year 2002
Number of shared co-authors 5
Tesa M Severson
Oncode Institute, The Netherlands Cancer Institute
Career Start Year 2002
Number of shared co-authors 10
Syed Haider
Institute of Cancer Research
Career Start Year 2002
Number of shared co-authors 29
Joel S Parker
Lineberger Cancer Center, University of North Carolina
Career Start Year 2002
Number of shared co-authors 9
Richard B Schwab
Department of Medicine and Moores Cancer Center, University of California San Diego
Career Start Year 2000
Number of shared co-authors 4
Celine Lefebvre
The Scripps Research Institute
Career Start Year 1999
Number of shared co-authors 0
Ole Christian Lingj??rde
University of Oslo
Career Start Year 1997
Number of shared co-authors 9
Jan Budczies
Institute of Pathology, University Hospital Heidelberg
Career Start Year 1996
Number of shared co-authors 4
Adam B Olshen
12224University of California san francisco
Career Start Year 1993
Number of shared co-authors 3

Collaborators

Jenny Chang-Claude
German Cancer Research Center (DKFZ)
Co-authored papers 16
Douglas F Easton
University of Cambridge
Co-authored papers 16
Christopher A Haiman
University of Southern California
Co-authored papers 15
Jan Lubinski
Pomeranian Medical University
Co-authored papers 15
Montserrat Garcia-Closas
National Cancer Institute
Co-authored papers 15
Paul D P Pharoah
Center for Cancer Genetic Epidemiology, University of Cambridge
Co-authored papers 15
Alison M Dunning
Co-authored papers 15
Diether Lambrechts
Co-authored papers 15
Fergus J Couch
Mayo Clinic
Co-authored papers 15
Georgia Chenevix-Trench
QIMR Berghofer Medical Research Institute
Co-authored papers 15
Per Hall
Co-authored papers 15
Graham G Giles
Co-authored papers 15
Peter A Fasching
Otto-Friedrich-University Bamberg
Co-authored papers 15
Vessela N Kristensen
Faculty of Clinical Medicine, University of Oslo
Co-authored papers 14
Roger L Milne
Co-authored papers 14
Irene L Andrulis
University of Toronto
Co-authored papers 14
Javier Ben??tez
Instituto de Salud Carlos III
Co-authored papers 13
Lodewyk F A Wessels
University Medical Centre Mannheim, University of Heidelberg
Co-authored papers 13
Loic Le Marchand
Co-authored papers 13
Hoda Anton-Culver
University of California irvine
Co-authored papers 13
Jonathan Beesley
QIMR Berghofer Medical Research Institute
Co-authored papers 11
Paolo Radice
Ospedale Circolo e Fondazione Macchi
Co-authored papers 11
Wei Zheng
Co-authored papers 11
Jonine D Figueroa
The Usher Institute, The University of Edinburgh
Co-authored papers 10
Xiao-Ou Shu
Co-authored papers 10
Stephen J Chanock
National Cancer Institute, National Institutes of Health
Co-authored papers 9
Julia A Knight
Co-authored papers 9
Janet E Olson
Mayo Clinic
Co-authored papers 8
John W M Martens
Erasmus Medical Center (MC) Cancer Institute
Co-authored papers 8
Anna H Wu
University of Southern California
Co-authored papers 8
Release 1.2